ARID1A and cholangiocarcinoma: Various molecular mechanisms, such as cell-cycle disruption, chromatin remodeling, oxidative stress damage, and DNA hypermethylation, are implicated in the relationship between ARID1A mutations and CCA pathogenesis [171].